Biofrontera (BFRI) has released an update.
On February 2, 2024, an institutional investor exercised pre-funded warrants to purchase 888,000 shares of a company’s common stock, originating from a previously reported public offering. With this exercise, all pre-funded warrants from that offering have been utilized, bringing the company’s total outstanding shares to 2,572,628.
For further insights into BFRI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
